Cedar Creek

Cedar Creek Partners

Micro-cap

Mar 2026 → Oct 2026

Our archive holds 4 letters from this strategy, behind 10 investment theses and positions in 17 companies. Every quote below is copied verbatim from the letter it came from.

4 letters in a year · follow all of Cedar Creek for every strategy.

Performance

as of Oct 31, 2026 · net of fees · USD

  • YTD
    +22.7%
    index +11.7%
  • Inception · /yr
    +15.2%

Index: S&P 500

Calendar years

  • 2025
    +29.6%
    index +17.8%
  • 2024
    +5.3%
    index +24.9%
  • 2023
    +20.3%
    index +26.2%
  • 2022
    +8.8%
    index −18.2%
  • 2021
    +38.9%
    index +28.6%
  • 2020
    +21.9%
    index +18.5%
  • 2019
    +34.5%
    index +31.2%
  • 2018
    −24.3%
    index −4.6%
  • 2017
    +11.4%
    index +21.7%
  • 2016
    +10.5%
    index +12.0%
Disclaimer

These figures are copied from the manager’s latest letter, as of Oct 31, 2026. They were extracted automatically, have not been verified by HF Best Ideas and may contain errors. They cover a single share class, in the currency and fee basis stated above; other share classes and your own returns will differ. This is not investment advice, nor an offer to buy or sell any fund. Past performance does not predict future returns.

Read full disclosures →

What it bought and sold

  • AddedHarbor DiversifiedSep 2026
    The fund was able to accumulate a large position at an average cost of $1.50 per share and has kept buying throughout the year as the price rose.
  • TrimmedPD-Rx PharmaceuticalsSep 2026
    Nothing has changed at PD-Rx Pharmaceuticals. It has been shrinking as a position.
  • ExitedPharmChemJun 2026
    With the sale of PharmChem in 2025 there is only one such holding in the fund at present.
  • AddedHarbor DiversifiedJun 2026
    We began accumulating shares of Harbor Diversified after its December 18, 2025, announcement that the company was selling its Air Wisconsin subsidiary and all related aircraft in three separate deals for aggregate consideration of $113 million.
  • TrimmedPD-Rx PharmaceuticalsJun 2026
    PD-Rx Pharmaceuticals has been shrinking as a position.
  • New positionQueen City InvestmentsJun 2026
    Queen City Investments (otc: QUCT) is a position the fund re-entered after attending their annual meeting in 2025.

Also held

Its investment theses

Every letter